carbostyril has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Ponti, F; Fusaroli, M; Giunchi, V; Menchetti, M; Poluzzi, E; Raschi, E; Rimondini Giorgini, R | 1 |
| Hamamura, T; Kodama, M | 1 |
| Bowden-Jones, H; Kitchenham, N; Smith, N | 1 |
| Khemiri, L; Moreira, T; Runeson, L | 1 |
| Carter, WG; Shillcutt, SD | 1 |
5 other study(ies) available for carbostyril and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
Topics: Antipsychotic Agents; Aripiprazole; Disruptive, Impulse Control, and Conduct Disorders; Dopamine; Dopamine Agonists; Humans; Hyperphagia; Lurasidone Hydrochloride; Olanzapine; Pharmacovigilance; Quinolones; Receptors, Serotonin; Thiophenes; United States; United States Food and Drug Administration | 2022 |
Aripiprazole-induced behavioural disturbance related to impulse control in a clinical setting.
Topics: Antipsychotic Agents; Aripiprazole; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2010 |
Pathological gambling and the treatment of psychosis with aripiprazole: case reports.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Male; Piperazines; Quinolones; Recurrence; Schizophrenia | 2011 |
Impulse control loss rapidly reversed by aripiprazole in a patient with concomitant bipolar disease type I and posttraumatic frontal lobe lesions.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain Injuries; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Middle Aged; Piperazines; Quinolones | 2011 |
Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
Topics: Antipsychotic Agents; Aripiprazole; Cyclohexanols; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Skin; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |